2021
Potential Benefits of Expanded COVID-19 Surveillance in the US
Holtgrave DR, Vermund SH, Wen LS. Potential Benefits of Expanded COVID-19 Surveillance in the US. JAMA 2021, 326: 381-382. PMID: 34264262, PMCID: PMC10767713, DOI: 10.1001/jama.2021.11211.Peer-Reviewed Original ResearchMeSH KeywordsAsymptomatic InfectionsCenters for Disease Control and Prevention, U.S.COVID-19HumansPublic Health SurveillanceUnited StatesVaccination
2013
Bacteremia as a Cause of Fever in Ambulatory, HIV-Infected Mozambican Adults: Results and Policy Implications from a Prospective Observational Study
Moon TD, Silva WP, Buene M, Morais L, Valverde E, Vermund SH, Brentlinger PE. Bacteremia as a Cause of Fever in Ambulatory, HIV-Infected Mozambican Adults: Results and Policy Implications from a Prospective Observational Study. PLOS ONE 2013, 8: e83591. PMID: 24386229, PMCID: PMC3875454, DOI: 10.1371/journal.pone.0083591.Peer-Reviewed Original ResearchConceptsProspective observational studyAmbulatory HIVFebrile patientsObservational studySusceptibility patternsLarge prospective observational studyT-lymphocyte countsSpecific antimicrobial therapyCause of feverCases of bacteremiaFirst-line antibioticsPeripheral health unitsAntimicrobial susceptibility patternsNon-physician cliniciansNon-typhoid SalmonellaResource-limited settingsBlood culture specimensLow CD4Presumptive antibioticsClinical characteristicsRecent feverClinical profileLower hemoglobinPrescribing practicesAntimicrobial therapy